AG
PRCT icon

Algert Global’s Procept Biorobotics PRCT Stock Holding History

Algert Global’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$937K Buy
41,498
+16,160
+64% +$405K 0.01% 978
2026
Q1 		$634K Sell
25,338
-32,550
-56% -$917K 0.01% 940
2025
Q4 		$1.82M Buy
57,888
+25,830
+81% +$857K 0.03% 729
2025
Q3 		$1.14M Buy
32,058
+2,450
+8% +$112K 0.02% 813
2025
Q2 		$1.71M Sell
29,608
-20,680
-41% -$1.17M 0.04% 676
2025
Q1 		$2.93M Buy
50,288
+26,440
+111% +$1.81M 0.07% 474
2024
Q4 		$1.92M Sell
23,848
-14,369
-38% -$1.23M 0.05% 619
2024
Q3 		$3.06M Buy
38,217
+11,190
+41% +$795K 0.08% 425
2024
Q2 		$1.65M Buy
+27,027
New +$1.61M 0.05% 523

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Algert Global's PRCT Position: Q2 2026 in Review

Algert Global increased its Procept Biorobotics (PRCT) stake by 64% in Q2 2026, buying an estimated $405K and bringing the position to 41,498 shares worth $937K. The position accounts for 0.01% of the portfolio, ranked #978.

Algert Global first reported a position in PRCT in Q2 2024 and has held it in 9 quarters since. The position peaked at $3.06M in Q3 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Algert Global held 41,498 shares of Procept Biorobotics worth $937K as of Q2 2026.
  • Algert Global bought 16,160 Procept Biorobotics shares in Q2 2026, an estimated $405K.
  • Procept Biorobotics made up 0.01% of Algert Global's portfolio in Q2 2026, its #978 holding.
  • Algert Global first reported a position in Procept Biorobotics in Q2 2024 and has held it in 9 quarters since.
  • Algert Global's Procept Biorobotics position peaked at $3.06M in Q3 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.